SoCal.Startups is building the most comprehensive resource for Southern California's tech scene.
SoCal.Startups
Be an early user
Pelage Pharmaceuticals, Inc. hero photo
Pelage Pharmaceuticals, Inc. logo

Pelage Pharmaceuticals, Inc.

Los Angeles, CA
LAST FUNDING
$134.0M
Series B

Pelage Pharmaceuticals, Inc. is developing regenerative medicines for hair loss, specifically PP405, a non-invasive, topically-applied small molecule solution that reactivates dormant hair follicles by targeting stem cells.

Funding history

RoundAmount
Series B$134.0M
SEC Form D filed
Nov 24, 2025·Aug 23, 2024·Jun 28, 2023

About Pelage Pharmaceuticals, Inc.

How much funding has Pelage Pharmaceuticals, Inc. raised?

Pelage Pharmaceuticals, Inc. has raised $134.0M in total funding. The most recent round was Series B.

Where is Pelage Pharmaceuticals, Inc. headquartered?

Pelage Pharmaceuticals, Inc. is headquartered in Los Angeles, CA.

What does Pelage Pharmaceuticals, Inc. do?

Pelage Pharmaceuticals, Inc. is developing regenerative medicines for hair loss, specifically PP405, a non-invasive, topically-applied small molecule solution that reactivates dormant hair follicles by targeting stem cells.

What problem does Pelage Pharmaceuticals, Inc. solve?

Existing hair loss treatments like minoxidil and PRP have limited efficacy and unclear mechanisms, target only secondary factors such as hormones, and no new FDA-approved options have emerged in almost three decades.

What's Pelage Pharmaceuticals, Inc.'s solution?

Pelage is developing PP405, a topically-applied small molecule designed to reactivate dormant hair follicle stem cells and regrow hair.

What makes Pelage Pharmaceuticals, Inc. different?

The approach is based on UCLA scientists' discovery of a metabolic switch that activates hair follicle stem cells, is non-hormonal and designed for all genders and hair types, and is applied topically without detectable systemic exposure.

What makes Pelage Pharmaceuticals, Inc. notable?

Pelage raised a $120 million Series B co-led by ARCH Venture Partners and Google's venture arm GV, with GV's Cathy Friedman appointed board chair.

Leadership

Heather Christofk
Executive Officer
Executive Officer, Director
LinkedIn ↗
Executive Officer, Director
LinkedIn ↗
Cathy Friedman
Director
Richard Heyman
Director
Industry
Healthcare
HQ
Los Angeles, CA
Raised
$134.0M
Stage
Series B

Related terms

❝ Cite this page

Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.

MLA
"Pelage Pharmaceuticals, Inc.: Funding & Investors." SoCal.Startups, September 3, 2026, https://socalstartups.io/companies/pelage-pharmaceuticals-inc. Accessed September 28, 2026.
APA
SoCal.Startups. (2026). Pelage Pharmaceuticals, Inc.: Funding & Investors. Retrieved September 28, 2026, from https://socalstartups.io/companies/pelage-pharmaceuticals-inc
WIKIPEDIA (CITE WEB)
{{cite web |title=Pelage Pharmaceuticals, Inc.: Funding & Investors |url=https://socalstartups.io/companies/pelage-pharmaceuticals-inc |website=SoCal.Startups |access-date=September 28, 2026}}
🏷 Embed this badge

Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.

Pelage Pharmaceuticals, Inc. featured on SoCal.Startups
HTML
<a href="https://socalstartups.io/companies/pelage-pharmaceuticals-inc" target="_blank" rel="noopener"><img src="https://socalstartups.io/badge.svg" width="220" height="52" alt="Pelage Pharmaceuticals, Inc. featured on SoCal.Startups" /></a>
MARKDOWN
[![Pelage Pharmaceuticals, Inc. featured on SoCal.Startups](https://socalstartups.io/badge.svg)](https://socalstartups.io/companies/pelage-pharmaceuticals-inc)